Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Medical Robots Market: By Type, By Therapeutic Area, By End-user and Region Forecast 2019-2030
The medical robots market size was valued at US$ 15,050.3 million in 2023 and is projected to reach US$ 35,848.5 million by 2030 at a CAGR of 13.5%. Moreover, the U.S. Medical Robots Market is projected to grow at a CAGR of 15.7% over the forecast period. The market refers to the industry that develops, manufactures, and deploys robotic devices and technologies to aid or conduct medical procedures. These robots are utilized in a variety of healthcare settings, including surgical aid, rehabilitation, hospital logistics, and diagnostics. They use innovative mechanical systems, artificial intelligence, and precision engineering to improve the accuracy, efficiency, and least invasiveness of medical procedures.
The market has grown significantly due to rising demand for minimally invasive surgical procedures, advances in robots technology, and increased healthcare investments. These technologies have advantages such as faster recovery times, more precision, and a lower risk of problems, which is driving their widespread acceptance in hospitals and clinics around the world. North America and Europe have the largest market shares due to established healthcare infrastructure, but the Asia-Pacific region is rapidly expanding, fuelled by technology improvements and rising healthcare expenditure. The market is divided into three major segments: robotic surgical systems, rehabilitation robots, and hospital/logistics robots, with advancements constantly expanding their scope and functionality.
The global market includes several medical robots companies such as Abbott, Panasonic, Renishaw, Siemens Healthineers, Smith + Nephew, Stryker, Medtronic, Johnson & Johnson, Zimmer Biotech among others.
By Type: In the Surgical robotic systems lead the market, owing to rising demand for minimally invasive surgical procedures. These systems, particularly in soft tissue and hard tissue surgeries, are changing the way complex procedures are carried out by improving precision, shortening recuperation times, and lowering the risk of problems. Innovations such as the da Vinci Surgical System have set new standards in this field, allowing surgeons to conduct complex procedures with more dexterity and visualization.
Soft tissue procedures lead this area due to its broad application in fields such as general surgery, urology, and gynaecology. Rising rates of chronic ailments such as cancer and cardiovascular disease have boosted the demand for robotic-assisted procedures that require precision and accuracy. The advantages of surgical robots, such as reduced postoperative pain, fewer surgical site infections, and shorter hospital stays, have fuelled their widespread acceptance in hospitals and surgical centres worldwide.
As healthcare providers prioritize patient outcomes and operational efficiency, the demand for surgical robotic systems continues to grow. Furthermore, improvements in robotic technology, such as AI-powered surgical aid and augmented reality integration, reinforce surgical robotic systems' position as the primary driver of the market.
By Therapeutic Area: General surgery stands as the leading therapeutic area, the market is driven by the widespread application of robotic systems in procedures such as hernia repairs, bariatric surgeries, and cholecystectomies. The adoption of robotic-assisted systems in general surgery has been propelled by their ability to offer superior precision, better visualization, and enhanced control compared to conventional laparoscopic or open surgical methods. Furthermore, the incorporation of modern technologies such as AI and 3D imaging into robotic systems has increased their efficacy in general surgery. These advancements improve preoperative planning and intraoperative decision-making, enhancing surgeon confidence and robotic system adoption. As healthcare facilities continue to engage in updating their surgical skills, general surgery remains the most important therapeutic area driving the growth.
By End-user: Hospitals and clinics are the largest and most prominent end user segments in the medical Robots industry, accounting for most of the robotic system installs and applications. This segment's supremacy originates from the widespread usage of robotic systems in difficult surgical operations, reducing hospital workflows, and improving patient care results. These hospitals prioritize innovative technologies to improve surgical precision, reduce complications, and maximize resource usage, making medical Robots a crucial component of modern healthcare delivery. Hospitals are ideal environments for implementing robotic systems in many disciplines such as general surgery, orthopaedics, and urology due to their high patient traffic and availability of specialist surgical units. These technologies help hospitals achieve greater procedural efficiency and shorter hospital stays, thereby improving patient turnover rates and overall cost-effectiveness.
Furthermore, prominent hospitals' rising investments in cutting-edge robotic technologies and training programs for medical professionals demonstrate their dedication to implementing new healthcare solutions. Trends such as the incorporation of AI into robotic systems and the growing emphasis on value-based treatment highlight hospitals and clinics as the primary end users in the medical Robots industry, driving continual innovation and market growth.
Study Period
2024-2030Base Year
2023CAGR
14.52%Largest Market
Asia-PacificFastest Growing Market
North America
The market is highly influenced by the growing demand for minimally invasive procedures (MIS) due to their benefits, which include shorter recovery times, fewer problems, and lower total healthcare costs. Robotic-assisted devices improve precision, dexterity, and control during difficult procedures, allowing surgeons to complete tasks more accurately than traditional techniques. This has resulted in their increased use in operations such as heart surgery, urology, and orthopaedics. Furthermore, an aging population and the rising prevalence of chronic disorders such as cancer and cardiovascular disease have increased the demand for sophisticated surgical options. Healthcare providers are progressively investing in robotic systems to meet these demands, fuelling market development.
Adoption is hampered due to high costs of procuring and maintaining medical robotic systems. Robotic surgical systems, such as the da Vinci Surgical System, need a significant upfront investment, making them difficult to implement in smaller healthcare facilities with restricted finances. Furthermore, maintenance expenses and the requirement for regular software updates increase the overall financial load, making it impossible for some institutions to justify the investment. Furthermore, the scarcity of experienced individuals to operate and maintain these systems hampers their implementation, particularly in underdeveloped countries where healthcare facilities may lack necessary training resources. Overcoming these economic and operational hurdles is critical to the wider deployment of medical Robots in all locations.
Emerging markets offer considerable development potential for the medical Robots industry as healthcare investments increase and infrastructure improves. Countries in Asia-Pacific, Latin America, and the Middle East are seeing greater adoption of robotic systems, owing to growing middle-class populations and increased knowledge of innovative healthcare technologies. Government actions to improve healthcare facilities and promote technology usage amplify this potential. For instance, the increased emphasis on medical tourism in countries such as India and Thailand present an ideal environment for the introduction of cutting-edge robotic systems, creating a lucrative opportunity for manufacturers to expand their global presence.
The integration of artificial intelligence (AI) is developing as a game-changing technology in the medical Robots industry. AI-powered medical robots improve precision, efficiency, and decision-making during surgical and diagnostic operations. These systems use powerful algorithms to evaluate massive volumes of data, allowing robots to do jobs with less human intervention and more accuracy. For example, AI-powered surgical robots help with complex surgeries by providing real-time insights such as tissue recognition and ideal incision courses, lowering the chance of errors and increasing patient outcomes. Similarly, robotic diagnostic systems use machine learning to quickly and accurately analyse medical imaging, such as CT scans or MRIs. AI also plays an important part in personalized medicine, as robots customize medicines to individual patient profiles by combining data from electronic health records and genetic analyses. Furthermore, the application of artificial intelligence improves medical professional training by simulating real-world events. This trend is being driven by the demand for minimally invasive procedures, advances in machine learning, and more investment in healthcare innovation. As AI advances, its integration with medical Robots is predicted to reshape the future of healthcare by improving operational efficiency and patient outcomes.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 15,050.3 million |
Market Size in 2030 |
US$ 35,848.5 million |
Market CAGR |
14.52% |
By Type |
|
By Therapeutic Area |
|
By End User |
|
By Region |
|
According to PBI Analyst, the medical Robots industry is expanding rapidly, driven by technological breakthroughs, increased demand for minimally invasive surgeries, and the rising frequency of chronic diseases. PBI analysts expect further growth as robotic systems improve surgical precision, shorten recuperation periods, and improve patient outcomes in a variety of therapeutic areas, including general surgery, orthopaedics, and urology.
The combination of artificial intelligence, machine learning, and augmented reality in robotic systems is driving market innovation, allowing for more autonomous and efficient surgeries. Hospitals and clinics are still the primary end potential consumers, spending extensively in robotic technologies to increase surgical efficiency and patient care.
Furthermore, the increasing use of rehabilitation and therapeutic robotic systems broadens the scope of medical Robots beyond surgery, particularly in post-operative care and physical rehabilitation. As the global healthcare sector embraces cutting-edge technology, the medical robots’ market is positioned for long-term expansion, with promising prospects in both developed and emerging regions.
Download Free Sample Report
The medical robots market size was valued at US$ 15,050.3 million in 2023 and is projected to reach US$ 35,848.5 million by 2030 at a CAGR of 13.5%.
The medical robots market is being driven by rising demand for minimally invasive operations and an increase in the frequency of chronic diseases that necessitate improved surgical procedures.
The Medical robots market key players are Intuitive Surgical (US), Stryker Corporation (US), Omnicell (US), Franka Emika (Germany), BD Rowa (US), ARxIUM (Canada), Hocoma AG (Switzerland)
The incorporation of artificial intelligence and machine learning into robotic systems is a significant trend, improving precision, adaptability, and autonomous capabilities in medical Robots.
1. Executive Summary |
2. Global Medical Robots Market Introduction |
2.1. Global Medical Robots Market - Taxonomy |
2.2. Global Medical Robots Market - Definitions |
2.2.1. Type |
2.2.2. Therapeutic Area |
2.2.3. End-user |
2.2.4. Region |
3. Global Medical Robots Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Key Developments |
4. Global Medical Robots Market By Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
4.1. Surgical Robotic Systems |
4.1.1. Soft Tissue Surgery |
4.1.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.1.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.1.1.3. Market Opportunity Analysis |
4.1.2. Hard Tissue Surgery |
4.1.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.1.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.1.2.3. Market Opportunity Analysis |
4.2. Rehabilitation Robotic Systems |
4.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.2.3. Market Opportunity Analysis |
4.3. Therapeutic Robotic Systems |
4.3.1. Assistive Robotic Systems |
4.3.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.3.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.3.1.3. Market Opportunity Analysis |
4.3.2. Exoskeleton Robotic Systems |
4.3.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.3.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3.2.3. Market Opportunity Analysis |
4.3.3. Others |
4.3.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.3.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3.3.3. Market Opportunity Analysis |
4.4. Radiosurgery Robotic Systems |
4.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.4.3. Market Opportunity Analysis |
4.5. Hospital & Pharmacy Robotic Systems |
4.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.5.3. Market Opportunity Analysis |
5. Global Medical Robots Market By Therapeutic Area, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
5.1. General Surgery |
5 1 1 Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Orthopaedic Surgery |
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Abdominal and Pelvic Surgery |
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Urologic Surgery |
5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Others |
5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
6. Global Medical Robots Market By End-user, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
6.1. Hospital & Clinics |
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Ambulatory Surgery Centre |
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Pharmacies |
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Rehabilitation Centre |
6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Others |
6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7. Global Medical Robots Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific |
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Latin America |
7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. MEA |
7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8. North America Medical Robots Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
8.1. Type Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1. Surgical Robotic Systems |
8.1.1.1. Soft Tissue Surgery |
8.1.1.2. Hard Tissue Surgery |
8.1.2. Rehabilitation Robotic Systems |
8.1.3. Therapeutic Robotic Systems |
8.1.3.1. Assistive Robotic Systems |
8.1.3.2. Exoskeleton Robotic Systems |
8.1.3.3. Others |
8.1.4. Radiosurgery Robotic Systems |
8.1.5. Hospital & Pharmacy Robotic Systems |
8.2. Therapeutic Area Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1. General Surgery |
8.2.2. Orthopaedic Surgery |
8.2.3. Abdominal and Pelvic Surgery |
8.2.4. Urologic Surgery |
8.2.5. Others |
8.3. End-user Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1. Hospital & Clinics |
8.3.2. Ambulatory Surgery Centre |
8.3.3. Pharmacies |
8.3.4. Rehabilitation Centre |
8.3.5. Others |
8.4. Country Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.4.1. USA |
8.4.2. Canada |
9. Europe Medical Robots Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
9.1. Type Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Surgical Robotic Systems |
9.1.1.1. Soft Tissue Surgery |
9.1.1.2. Hard Tissue Surgery |
9.1.2. Rehabilitation Robotic Systems |
9.1.3. Therapeutic Robotic Systems |
9.1.3.1. Assistive Robotic Systems |
9.1.3.2. Exoskeleton Robotic Systems |
9.1.3.3. Others |
9.1.4. Radiosurgery Robotic Systems |
9.1.5. Hospital & Pharmacy Robotic Systems |
9.2. Therapeutic Area Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1. General Surgery |
9.2.2. Orthopaedic Surgery |
9.2.3. Abdominal and Pelvic Surgery |
9.2.4. Urologic Surgery |
9.2.5. Others |
9.3. End-user Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1. Hospital & Clinics |
9.3.2. Ambulatory Surgery Centre |
9.3.3. Pharmacies |
9.3.4. Rehabilitation Centre |
9.3.5. Others |
9.4. Country Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1. Germany |
9.4.2. UK |
9.4.3. France |
9.4.4. Italy |
9.4.5. Spain |
9.4.6. Rest of Europe |
10. Asia Pacific Medical Robots Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
10.1. Type Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Surgical Robotic Systems |
10.1.1.1. Soft Tissue Surgery |
10.1.1.2. Hard Tissue Surgery |
10.1.2. Rehabilitation Robotic Systems |
10.1.3. Therapeutic Robotic Systems |
10.1.3.1. Assistive Robotic Systems |
10.1.3.2. Exoskeleton Robotic Systems |
10.1.3.3. Others |
10.1.4. Radiosurgery Robotic Systems |
10.1.5. Hospital & Pharmacy Robotic Systems |
10.2. Therapeutic Area Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1. General Surgery |
10.2.2. Orthopaedic Surgery |
10.2.3. Abdominal and Pelvic Surgery |
10.2.4. Urologic Surgery |
10.2.5. Others |
10.3. End-user Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1. Hospital & Clinics |
10.3.2. Ambulatory Surgery Centre |
10.3.3. Pharmacies |
10.3.4. Rehabilitation Centre |
10.3.5. Others |
10.4. Country Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1. China |
10.4.2. India |
10.4.3. Japan |
10.4.4. South Korea |
10.4.5. ASEAN Countries |
10.4.6. Rest of APAC |
11. Latin America Medical Robots Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
11.1. Type Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Surgical Robotic Systems |
11.1.1.1. Soft Tissue Surgery |
11.1.1.2. Hard Tissue Surgery |
11.1.2. Rehabilitation Robotic Systems |
11.1.3. Therapeutic Robotic Systems |
11.1.3.1. Assistive Robotic Systems |
11.1.3.2. Exoskeleton Robotic Systems |
11.1.3.3. Others |
11.1.4. Radiosurgery Robotic Systems |
11.1.5. Hospital & Pharmacy Robotic Systems |
11.2. Therapeutic Area Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1. General Surgery |
11.2.2. Orthopaedic Surgery |
11.2.3. Abdominal and Pelvic Surgery |
11.2.4. Urologic Surgery |
11.2.5. Others |
11.3. End-user Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1. Hospital & Clinics |
11.3.2. Ambulatory Surgery Centre |
11.3.3. Pharmacies |
11.3.4. Rehabilitation Centre |
11.3.5. Others |
11.4. Country Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1. Brazil |
11.4.2. Mexico |
11.4.3. Argentina |
11.4.4. Rest of Latin America |
12. MEA Medical Robots Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
12.1. Type Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Surgical Robotic Systems |
12.1.1.1. Soft Tissue Surgery |
12.1.1.2. Hard Tissue Surgery |
12.1.2. Rehabilitation Robotic Systems |
12.1.3. Therapeutic Robotic Systems |
12.1.3.1. Assistive Robotic Systems |
12.1.3.2. Exoskeleton Robotic Systems |
12.1.3.3. Others |
12.1.4. Radiosurgery Robotic Systems |
12.1.5. Hospital & Pharmacy Robotic Systems |
12.2. Therapeutic Area Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1. General Surgery |
12.2.2. Orthopaedic Surgery |
12.2.3. Abdominal and Pelvic Surgery |
12.2.4. Urologic Surgery |
12.2.5. Others |
12.3. End-user Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1. Hospital & Clinics |
12.3.2. Ambulatory Surgery Centre |
12.3.3. Pharmacies |
12.3.4. Rehabilitation Centre |
12.3.5. Others |
12.4. Country Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1. GCC Countries |
12.4.2. Israel |
12.4.3. South Africa |
12.4.4. Rest of MEA |
13. Competition Landscape |
13.1. Strategic Dashboard of Top Market Players |
13.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
13.2.1. Abbott |
13.2.2. Panasonic |
13.2.3. Renishaw |
13.2.4. Siemens Healthineers |
13.2.5. Smith + Nephew |
13.2.6. Stryker |
13.2.7. Medtronic |
13.2.8. Johnson & Johnson |
13.2.9. Zimmer Biotech |
14. Research Methodology |
15. Key Assumptions and Acronyms |
Key Market Players